" /> Docetaxel/Pertuzumab/Trastuzumab Regimen - CISMeF





Preferred Label : Docetaxel/Pertuzumab/Trastuzumab Regimen;

NCIt synonyms : Pertuzumab/Trastuzumab/Docetaxel; Pertuzumab-Trastuzumab-Docetaxel; Pertuzumab Trastuzumab Docetaxel; Pertuzumab-Trastuzumab-Docetaxel Regimen; Taxotere/Herceptin/Pertuzumab; THP (Taxotere) Regimen; Pertuzumab/Trastuzumab/Docetaxel Regimen;

NCIt related terms : THP; THP (Docetaxel); THP (Docetaxel) (trastuzumab-dttb); THP (Docetaxel) (trastuzumab-herw); THP (Docetaxel) (trastuzumab-zerc); THP (Docetaxel) (trastuzumab-anns); THP (Docetaxel) (trastuzumab-pkrb); THP (Docetaxel) (trastuzumab-qyyp); THP (Docetaxel) (trastuzumab-dkst); THP (Docetaxel) (trastuzumab-strf);

NCIt definition : A regimen consisting of pertuzumab, trastuzumab and docetaxel that can be used in the treatment of breast cancer.;

NCIt note : Source: NCCN Guidelines 2017;

NCI Metathesaurus CUI : CL524987;

Codes from synonyms : 6027; 128837; 129225; 129128; 128934; 129322; 129419; 129031; 141479;

Détails


Position du mot-clé dans l'(les) arborescence(s) : arborescence

Vous pouvez consulter :


Nous contacter.
29/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.